Literature DB >> 15784591

Human leukocyte antigen-DQ8 transgenic mice: a model to examine the toxicity of aerosolized staphylococcal enterotoxin B.

Chad J Roy1, Kelly L Warfield, Brent C Welcher, Raoul F Gonzales, Tom Larsen, Julie Hanson, Chella S David, Theresa Krakauer, Sina Bavari.   

Abstract

Staphylococcal enterotoxins (SEs) belong to a large group of bacterial exotoxins that cause severe immunopathologies, especially when delivered as an aerosol. SEs elicit the release of lethal amounts of cytokines by binding to major histocompatibility complex (MHC) class II and cross-linking susceptible T-cell receptors. Efforts to develop effective therapeutic strategies to protect against SEs delivered as an aerosol have been hampered by the lack of small animal models that consistently emulate human responses to these toxins. Here, we report that human leukocyte antigen-DQ8 (HLA-DQ8) transgenic (Tg) mice, but not littermate controls, succumbed to lethal shock induced by SEB aerosols without potentiation. Substantial amounts of perivascular edema and inflammatory infiltrates were noted in the lungs of Tg mice, similar to the pathology observed in nonhuman primates exposed by aerosol to SEB. Furthermore, the observed pathologies and lethal shock correlated with an upsurge in proinflammatory cytokine mRNA gene expression in the lungs and spleens, as well as with marked increases in the levels of proinflammatory circulating cytokines in the Tg mice. Unlike the case for littermate controls, telemetric evaluation showed significant hypothermia in Tg mice exposed to lethal doses of SEB. Taken together, these results show that this murine model will allow for the examination of therapeutics and vaccines developed specifically against SEB aerosol exposure and possibly other bacterial superantigens in the context of human MHC class II receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784591      PMCID: PMC1087414          DOI: 10.1128/IAI.73.4.2452-2460.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Inhibition of bacterial superantigens by peptides and antibodies.

Authors:  K Visvanathan; A Charles; J Bannan; P Pugach; K Kashfi; J B Zabriskie
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Staphylococcal enterotoxin B induces fever, brain c-Fos expression, and serum corticosterone in rats.

Authors:  L E Goehler; R P Gaykema; M K Hansen; J L Kleiner; S F Maier; L R Watkins
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-05       Impact factor: 3.619

3.  Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.

Authors:  G Arad; R Levy; D Hillman; R Kaempfer
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

Review 4.  Streptococcal toxic shock syndrome associated with necrotizing fasciitis.

Authors:  D L Stevens
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

5.  Lessons from animal models for human autoimmune diseases.

Authors:  V Taneja; C S David
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

6.  Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock.

Authors:  G Arad; D Hillman; R Levy; R Kaempfer
Journal:  J Leukoc Biol       Date:  2001-06       Impact factor: 4.962

Review 7.  HLA class II transgenic mice as models of human diseases.

Authors:  V Taneja; C S David
Journal:  Immunol Rev       Date:  1999-06       Impact factor: 12.988

8.  Immediate responses of leukocytes, cytokines and glucocorticoid hormones in the blood circulation of monkeys following challenge with aerosolized staphylococcal enterotoxin B.

Authors:  C F Weng; J L Komisar; R E Hunt; A J Johnson; M L Pitt; D L Ruble; J Tseng
Journal:  Int Immunol       Date:  1997-12       Impact factor: 4.823

9.  Effect of a cyclic heptapeptide based on the human CD4 domain 1 CC' loop region on murine experimental allergic encephalomyelitis: inhibition of both primary and secondary responses.

Authors:  A E Edling; S Choksi; Z Huang; R Korngold
Journal:  J Neuroimmunol       Date:  2001-01-01       Impact factor: 3.478

10.  Telemetric evaluation of body temperature and physical activity as predictors of mortality in a murine model of staphylococcal enterotoxic shock.

Authors:  K D Vlach; J W Boles; B G Stiles
Journal:  Comp Med       Date:  2000-04       Impact factor: 0.982

View more
  29 in total

1.  Acute systemic immune activation following conjunctival exposure to staphylococcal enterotoxin B.

Authors:  Govindarajan Rajagopalan; Michele K Smart; Robin Patel; Chella S David
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

2.  Early gene expression changes induced by the bacterial superantigen staphylococcal enterotoxin B and its modulation by a proteasome inhibitor.

Authors:  Govindarajan Rajagopalan; Ashenafi Y Tilahun; Yan W Asmann; Chella S David
Journal:  Physiol Genomics       Date:  2009-03-31       Impact factor: 3.107

3.  Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology.

Authors:  Peter A Szabo; Ankur Goswami; Delfina M Mazzuca; Kyoungok Kim; David B O'Gorman; David A Hess; Ian D Welch; Howard A Young; Bhagirath Singh; John K McCormick; S M Mansour Haeryfar
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

4.  Determining the immunological characteristics of a novel human monoclonal antibody developed against staphylococcal enterotoxin B.

Authors:  Yuanyuan Liu; Zhen Song; Shuang Ge; Jinyong Zhang; Limin Xu; Feng Yang; Dongshui Lu; Ping Luo; Jiang Gu; Quanming Zou; Hao Zeng
Journal:  Hum Vaccin Immunother       Date:  2020-04-10       Impact factor: 3.452

5.  Human leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndrome.

Authors:  Ashenafi Y Tilahun; Eric V Marietta; Tsung-Teh Wu; Robin Patel; Chella S David; Govindarajan Rajagopalan
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

6.  Bacterial Toxins-Staphylococcal Enterotoxin B.

Authors:  Bettina C Fries; Avanish K Varshney
Journal:  Microbiol Spectr       Date:  2013-12

7.  Interference of the T Cell and Antigen-Presenting Cell Costimulatory Pathway Using CTLA4-Ig (Abatacept) Prevents Staphylococcal Enterotoxin B Pathology.

Authors:  Sarah J C Whitfield; Chris Taylor; Jane E Risdall; Gareth D Griffiths; James T A Jones; E Diane Williamson; Sjoerd Rijpkema; Luisa Saraiva; Sandrine Vessillier; A Christopher Green; Alun J Carter
Journal:  J Immunol       Date:  2017-03-20       Impact factor: 5.422

8.  Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice.

Authors:  Govindarajan Rajagopalan; Koji Iijima; Manisha Singh; Hirohito Kita; Robin Patel; Chella S David
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

9.  Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo.

Authors:  Teresa Krakauer; Marilyn Buckley; Haleem J Issaq; Stephen D Fox
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

10.  Differential susceptibility of inbred mouse strains to Burkholderia thailandensis aerosol infection.

Authors:  Lisa A Morici; Julie Heang; Tim Tate; Peter J Didier; Chad J Roy
Journal:  Microb Pathog       Date:  2009-10-21       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.